Yield10 Bioscience to prioritize commercialization of Omega-3 Camelina program
In Massachusetts, Yield10 Bioscience has taken the strategic decision to prioritize in 2024 the execution of activities intended to accelerate and advance the Omega-3 Camelina program toward commercialization. Yield10 also reported that it has completed contra season production in Chile of Omega-3 EPA8 Camelina, which produces the eicosapentaenoic acid (“EPA”) component of the omega-3 oil […]
